Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections reduce hunger signals in your brain and slow how fast your stomach empties, creating sustained weight loss over weeks and months. Many patients wonder if their medication is actually working during the critical first month, especially since scale movement can be slow initially. Knowing what to track beyond the number on the scale helps you recognize real progress and build confidence in your treatment plan.

Early Signs Semaglutide Is Working in Week One Through Four

The first noticeable effect usually happens within days: reduced hunger and food cravings. Your appetite signals shift because semaglutide activates GLP-1 receptors in areas of your brain that control eating desire. You may find that foods you normally crave no longer appeal to you, or portions that satisfied you before now feel too large.

During weeks two through four, many patients report feeling fuller faster at meals. This happens because semaglutide slows gastric emptying, meaning food stays in your stomach longer. Eating smaller meals without feeling deprived is one of the most reliable early indicators that the medication is engaging with your body's appetite-control system.

Some weight loss typically appears by week three or four, though the amount varies. Initial loss often includes water weight alongside fat reduction. Tracking your weight weekly at the same time of day helps you spot downward trends even if week-to-week fluctuations occur.

Measuring Progress Beyond the Scale

Your clothes fitting differently is often a better progress marker than daily weigh-ins. Semaglutide causes fat loss while preserving lean muscle, so the circumference of your waist, hips, and chest may shrink noticeably before significant scale movement. Taking photos every two weeks in the same lighting and position provides visual proof that your body composition is changing.

Energy levels typically improve within the first month as your body begins using stored fat for fuel. You may notice you can climb stairs without fatigue, exercise longer, or finish your workday with more alertness. These functional improvements signal that metabolic health is shifting in a positive direction.

Blood sugar stability often improves quickly with semaglutide use. If you tracked hunger crashes or energy dips before treatment, you'll likely notice those episodes disappear. Steady blood sugar means fewer cravings and more consistent focus throughout your day, reflecting that your glucose metabolism is stabilizing.

Dose Adjustments and What Month Two Through Six Look Like

PlexusDx semaglutide injections start at $149 per month, with the pricing holding steady as your dose increases. Your provider may adjust your dose upward every four weeks based on how well you're tolerating the medication and your appetite response. Your dose may need to go up. Your price won't.

In month two through three, weight loss typically accelerates as your body fully adapts to the medication. Most patients see two to four pounds of loss per week during this phase, though individual results vary based on starting weight, diet, and activity level. This is when you'll likely notice the most dramatic changes in how your clothes fit and how you feel.

By month four through six, you're in the maintenance phase of your dose. Your appetite suppression is stable, and weight loss becomes more predictable. This is an ideal time to evaluate your progress and decide if you need genetic testing to optimize your treatment plan further.

Using Genetic Insights to Optimize Your Semaglutide Response

The PlexusDx Precision Peptide Genetic Test examines your genetic variants in key appetite-control pathways, including GLP1R rs6923761 and MC4R rs17782313. These variants influence how strongly your body responds to semaglutide and whether you may benefit from combination therapy. Understanding your genetic predispositions helps your provider personalize your treatment for maximum effectiveness.

If genetic testing reveals that you have lower baseline GLP1R sensitivity, your provider might recommend the GLP-Squared combination injection, which pairs semaglutide with tirzepatide for dual-pathway activation. This personalized approach addresses your specific metabolic profile rather than using a one-size-fits-all protocol. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, giving you data-driven direction for your weight loss journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to see weight loss results on semaglutide?

Most patients notice reduced appetite within three to five days, but visible scale movement typically takes two to three weeks. Meaningful weight loss—two to four pounds per week—usually begins in weeks three through four as your body fully adapts to the medication.

Is appetite suppression the same as the medication working?

Yes, reduced hunger is the primary mechanism by which semaglutide creates weight loss. When you eat less without feeling deprived, semaglutide is successfully activating GLP-1 receptors in your brain that control satiety and food desire.

What if I'm not seeing results after one month?

One month is still early in treatment. PlexusDx providers typically wait four to eight weeks before adjusting your dose or considering alternative approaches. If you have genetic variants that reduce GLP1R sensitivity, adding tirzepatide or genetic testing may unlock better results.

Can I take semaglutide long-term, or is it just for rapid weight loss?

Semaglutide is designed for long-term use. Clinical trials show sustained weight loss over 68 weeks with ongoing therapy. Most patients continue treatment for months to years, maintaining their results and lifestyle improvements.

Does the Precision Peptide Genetic Test predict if semaglutide will work for me?

The Precision Peptide Genetic Test identifies your specific genetic variants in 14 appetite and metabolic pathways, including GLP1R and FTO variants.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves